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A B S T R A C T
The STR Sequencing Project (STRSeq) was initiated to facilitate the description of sequence-based alleles at the
Short Tandem Repeat (STR) loci targeted in human identiﬁcation assays. This international collaborative eﬀort,
which has been endorsed by the ISFG DNA Commission, provides a framework for communication among la-
boratories. The initial data used to populate the project are the aggregate alleles observed in targeted sequencing
studies across four laboratories: National Institute of Standards and Technology (N = 1786), Kings College
London (N = 1043), University of North Texas Health Sciences Center (N = 839), and University of Santiago de
Compostela (N = 944), for a total of 4612 individuals. STRSeq data are maintained as GenBank records at the
U.S. National Center for Biotechnology Information (NCBI), which participates in a daily data exchange with the
DNA DataBank of Japan (DDBJ) and the European Nucleotide Archive (ENA). Each GenBank record contains the
observed sequence of a STR region, annotation (“bracketing”) of the repeat region and ﬂanking region poly-
morphisms, information regarding the sequencing assay and data quality, and backward compatible length-
based allele designation. STRSeq GenBank records are organized within a BioProject at NCBI (https://www.ncbi.
nlm.nih.gov/bioproject/380127), which is sub-divided into: commonly used autosomal STRs, alternate auto-
somal STRs, Y-chromosomal STRs, and X-chromosomal STRs. Each of these categories is further divided into
locus-speciﬁc BioProjects. The BioProject hierarchy facilitates access to the GenBank records by browsing,
BLAST searching, or ftp download. Future plans include user interface tools at strseq.nist.gov, a pathway for
submission of additional allele records by laboratories performing population sample sequencing and interaction
with the STRidER web portal for quality control (http://strider.online).
1. Introduction
As the forensic DNA community evaluates the potential of sequen-
cing applications for Short Tandem Repeat (STR) loci, it is imperative to
deﬁne the allelic diversity in these regions of the human genome. Large-
scale sequencing projects within the broader genomics community may
use shorter read chemistries (e.g. 100 bp) and may not describe re-
petitive regions due to their complexity and non-conformity to typical
alignment parameters [1]. Additionally, knowledge of the forensic lit-
erature is needed to report STR sequences in the same manner estab-
lished by the forensic community.
Even within forensic sequencing studies, there are diﬀerences in the
reporting of sequence-based STR alleles. Names of convenience such as
20(a) [2] or FL1X20 [3] have not been standardized and may create
confusion about the speciﬁc allele being reported. There may be dif-
ferences in format for the compression or “bracketing” of STR se-
quences, such as ATAG[9] [4,5] or [ATAG]9 [6] or [ATAG]9 [7].
More importantly, there may be diﬀerences in strand reporting where
choice of the forward strand will match the reference sequence direc-
tion, and choice of the reverse strand aligns the sequence in the op-
posite direction. The DNA Commission of the ISFG on minimal no-
menclature requirements in 2016 recommended reporting all sequences
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in the forward strand orientation [8]. However, some loci were his-
torically reported on the reverse strand [9]. In particular, STRs for
which the reported strand has changed over time may diﬀer in re-
porting where the repeat region begins. This can result in shifted (dif-
ferent) allele number designations for the same sequence [8]. Lastly,
the recovery and reporting of varying lengths of ﬂanking regions (and
hence ﬂanking region variants) is inherent to diﬀerences in kit designs
and bioinformatic pipelines.
The international forensic DNA community continues to develop
guidance on STR sequence nomenclature, and additional resources for
quality control of STR sequence data are being developed [10]. How-
ever, the need for standardization is immediate. A 2016 survey was
recently published by the European Network of Forensic Science In-
stitutes (ENFSI) DNA Working Group [11], in which over half of the 33
responding laboratories have already purchased at least one sequencing
instrument. The respondents (primarily composed of government for-
ensic laboratories across 25 countries) reported lack of nomenclature and
reporting standards as the highest ranking scientiﬁc and legal challenge
for the implementation of new sequencing technologies in forensic
genetics. Also in 2016, the Applied Genetics Group of the U.S. National
Institute of Standards and Technology (NIST) queried forensic labora-
tories to assess the utility of STR reference sequences for loci of forensic
interest. The feedback received from 22 laboratories (representing 11
countries) mirrored the ENSFI survey with strong support for the de-
velopment of STR sequence nomenclature resources.
In response to this need, NIST partnered with the U.S. National
Center for Biotechnology Information (NCBI), leveraging NIST’s over
20-year history supporting the forensic STR typing community [12] and
NCBI’s extensive infrastructure for accepting, maintaining and serving
DNA sequence data. Through this partnership, the STR Sequencing
Project (STRSeq) has been initiated to facilitate the description of se-
quence-based alleles at the STRs targeted in human identiﬁcation as-
says. This resource consists of a curated catalog of sequence diversity at
forensic STR loci, along with the key elements of nomenclature con-
forming to current guidelines [8], and will serve as the data backbone
during this time of transition, as well as a stable resource for the future.
2. Samples and submission strategy
The initial data used to populate STRSeq are the aggregate alleles
observed in targeted sequencing studies of single source samples across
four laboratories: NIST, Kings College London (KCL), University of
North Texas Health Science Center (UNT), and University of Santiago
de Compostela (USC), for a total of 4612 individuals. The number of
alleles aggregated diﬀers by locus due to variable multiplex perfor-
mance and quality requirements described in Section 3. As only ag-
gregate alleles are displayed, the source of the alleles is anonymized.
The targeted sequence data used in STRSeq either have been, or are
expected to be published by the submitting laboratory ([6,13], addi-
tional manuscripts in preparation). Records will be added to the STRSeq
BioProject in sets, largely coinciding with associated publications, as
follows:
NIST: N = 1786 samples from multiple sources: 1) N = 665 liquid
blood samples purchased from Interstate Blood Bank (Memphis, TN)
and Millennium Biotech, Inc. (Ft. Lauderdale, FL) with self-declared
ancestries from three U.S. population groups: Caucasian, African
American, and Hispanic; 2) N = 781 buccal swabs provided by DNA
Diagnostics Center (Fairﬁeld, OH) from paternity testing samples with
self-declared ancestries from four U.S. population groups: Caucasian,
African American, Asian and Hispanic; 3) N = 297 buccal swabs col-
lected from anonymous volunteers of self-reported, diverse ancestries,
provided by the George Washington University; and 4) N = 43 control
samples and reference materials. All samples have been sequenced with
the ForenSeq system (Illumina) and a subset (> 600 samples) has
overlapping sequence data from the PowerSeq Auto-Y assay (Promega).
In addition, for the majority of these samples, capillary electrophoresis
(CE) STR data is available at all ForenSeq and PowerSeq Auto-Y loci
([14,15] and unpublished data).
KCL: N = 1043 samples were obtained from consenting adult vo-
lunteers resident in the U.K. The samples relate to six U.K. population
groups with self-declared ancestries of: White British, West African,
North East African, South Asian, Chinese and Middle Eastern. All
samples have been sequenced with the ForenSeq system and ad-
ditionally genotyped with at least two commonly available CE kits.
UNT: N = 839 samples which have been described in associated
sequence-based allele frequency publications and were sequenced with
the ForenSeq system [6,13].
USC: N = 944 samples from the HGDP-CEPH diversity panel cell-
line DNAs from 51 diverse populations were sequenced with the
ForenSeq system.
Initially, STRSeq records will be created for the STR loci targeted in
the aforementioned assays; additional records will be created as sam-
ples are sequenced with other available commercial assays, e.g.
Precision ID GlobalFiler NGS STR Panel (Thermo Fisher Scientiﬁc). If
new STR loci (see [16]) are targeted in commercially available assays
launched in the future, additional records will be created.
A single laboratory will be indicated as having submitted each re-
cord. The association of a submitting laboratory with a record does not
imply “discovery” of a sequence variant; rather the designation is
simply the organization that initially provided the sequence and
maintains the supporting data. For the initial data set, NIST will be the
submitting laboratory of all sequences generated at NIST and the other
laboratories will be the submitting laboratory of those sequences gener-
ated at that speciﬁc laboratory for which records do not already exist in
the database. Duplicate records will not be created, which will gen-
erally result in a decreasing number of new sequence records as suc-
cessive sample sets are added. Fig. 1 outlines an example submission
strategy of non-duplicate allele records that might be expected from a
typical highly polymorphic STR such as D12S391.
3. BioProject hierarchy and record format
The BioProject hierarchy serves to organize the GenBank records
(Table 1). The highest-level STRSeq umbrella project contains four sub-
umbrella projects: (a) Commonly Used Autosomal STR Loci, (b) Al-
ternate Autosomal STR Loci, (c) Y-Chromosomal STR Loci, and (d)
X-Chromosomal STR Loci. These sub-umbrella projects are divided
further into locus-speciﬁc data-level projects which contain the Gen-
Bank sequence record data. Each umbrella and data-level project has a
corresponding accession number, e.g. PRJNA380127 is the STRSeq
umbrella project, PRJNA380345 is the Commonly Used Autosomal
STR Loci sub-umbrella project, and PRJNA380554 is the TPOX Se-
quence-Based Alleles project (the common PRJNA preﬁx identiﬁes the
six-digit number as a BioProject). Entering one of these accession
numbers at https://www.ncbi.nlm.nih.gov/bioproject allows direct
access to the umbrella or data-level project of interest. Each BioProject
page contains additional links for up, down, and cross navigation.
Table 1 contains direct links to STRSeq umbrella and data-level pro-
jects.
The sequence records in GenBank are ﬂat ﬁles of speciﬁed format
that can be downloaded and parsed en masse (see Fig. 2 for an example
record for the TPOX locus). Starting from the bottom of the record, in a
section labeled ORIGIN, users will ﬁnd the full sequence that was re-
ported by the submitting laboratory. The length of reported sequence is
dependent upon the assay and the quality of the ﬂanking sequence data,
but generally will be consistent with the assay-speciﬁc conﬁguration
ﬁles published in [17]. Above the sequence is the FEATURES table,
which includes the position of the repeat region within the sequence,
the position and dbSNP rs number of variations in the ﬂanking regions
(when applicable), and the subset of sequence that was observed with
diﬀerent commercial assays (when applicable). Each feature can be
selected in order to highlight the appropriate region in the sequence
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string. SNP rs numbers are hyperlinked to dbSNP, allowing users to
navigate and access frequency information quickly. If the poly-
morphism has not been assigned a dbSNP reference number, the
GRCh38 coordinate is given, and the ﬁeld will be updated if an rs
number is assigned later or if the assembly is updated.
Above the FEATURES table is the structured comments section (oﬀset
with ##humanSTR-START## and ##humanSTR-END##), which
contains ﬁeld-based information relevant to STRSeq records. The given
Bracketed repeat is intended to be consistent with the guidance of the
ISFG nomenclature commission [8]. Speciﬁc to STRSeq records is the
lower-case formatting of selected bases within the Bracketed repeat,
which highlights sequence tracts that are not counted toward the
length-based allele designation (when applicable, e.g. D19S433 14 al-
lele will be presented as: [AAGG] aaag [AAGG] tagg [AAGG]12). The
Sequencing technology ﬁeld lists the commercial assay(s) and in-
strument(s) used to generate the sequence data. The Coverage ﬁeld
lists the minimum threshold of reads observed for the reported se-
quence. The current threshold for STRSeq record creation is> 30X.
This is consistent with the default minimum “interpretation threshold”
implemented in one commercial software, corresponding to the only
relevant commercial assay with a published developmental validation
[18] at the time of writing. This threshold will continue to be evaluated
in the future as additional developmental validations are published. The
Length-based tech. ﬁeld lists the assay and instrument used to gen-
erate the Length-based allele given. Often a sequence will have been
observed in multiple samples. The length-based information in each
record indicates that, for at least one sample, the speciﬁed length-based
allele was generated with the given length-based technology. This ap-
proach is not meant to be comprehensive; variation in the length-based
allele among individuals or assays can result from indels in ﬂanking
regions. In some instances, length-based allele conﬁrmation may not be
possible, such as the lack of a CE assay for STRs targeted by commercial
sequencing assays but not previously in common use. When a length-
based allele conﬁrmation has not been performed, the Length-based
allele ﬁeld will indicate e.g. “7 (Inferred from sequence)” and the
Length-based tech. ﬁeld will contain “Not reported”. The remaining
information in the structured comments section orients the sequence on
the chromosome and will be updated along with the reference sequence
assembly.
Above the structured comments section is the COMMENT block,
which is identical across records and recapitulates this paper. Above the
COMMENT block are references. REFERENCE 1 will be this paper and
REFERENCE 2 identiﬁes the submitting laboratory. The remaining top-
most ﬁelds contain information for GenBank record organization. The
ACCESSION and VERSION number is the GenBank sequence identiﬁer
(e.g. MF044256.1 in Fig. 2). If future commercial assay typing provides
additional ﬂanking sequence, the updated sequence will become e.g.
MF044256.2 (coexisting with MF044256.1). If the additional ﬂanking
sequence reveals a polymorphism, the additional sequence consistent
with the reference sequence becomes e.g. MF044256.2 and a new re-
cord is created for the additional sequence which diﬀers from the re-
ference sequence.
The DEFINITION line near the top of the record is the descriptor
present in a list of sequences (see https://www.ncbi.nlm.nih.gov/
nuccore/?term=strseq+tpox), and will uniquely identify each allele
with components of the record itself. In addition, the top of each record
contains hyperlinks to the FASTA sequence, which can be downloaded,
and a Graphics view (Fig. 3). This graphical display presents an in-
teractive version of the sequence (displaying forward and reverse
strands) and the features identiﬁed in the GenBank record: the repeat
region, the region(s) reported from each available sequencing tech-
nology, and any associated ﬂanking region polymorphisms. The in-
formation shown in Graphics view is dependent on the Tracks selected
in the viewer. All available information for the record is displayed si-
multaneously by selecting both the Sequence and Aggregate features
Track. More information and tutorials on the NCBI Sequence Viewer
can be found at https://www.ncbi.nlm.nih.gov/tools/sviewer.
4. Typical use cases
Several use cases for STRSeq have been identiﬁed based on feedback
from the forensic community:
I. As a teaching tool to explore STR sequences. The STRSeq BioProject
is expected to be useful to forensic operational, academic, and
commercial laboratories interested in sequencing STRs as it allows
the viewing and downloading of repeat region motifs, ﬂanking re-
gion polymorphisms, and commercial assay overlap.
II. As the data backbone for software development. This catalog of
sequences with associated forensic formatting and stable links to
GenBank records facilitates development of STR sequencing
methods and bioinformatic pipelines that conform to agreed variant
data frameworks.
III. To provide a quality control function for the evaluation of rare se-
quences. When a sequence is observed in forensic casework that
was not observed in initial validation studies or in the implemented
Fig. 1. (a) Venn diagram demonstrating the overlap of D12S391 sequence-based alleles observed among the four laboratories, and the total number of unique sequence-based alleles
observed within each laboratory. (b) Submission strategy for 157 unique sequence-based alleles observed at the D12S391 locus. The 105 unique alleles generated at NIST form the basis of
STRSeq records. Subsequent submissions from KCL, UNT, and USC will add records for sequences generated at each laboratory for which records do not already exist (25, 9, and 18
records, respectively).
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allele frequency database, a STRSeq BLAST search determines if a
similar or identical sequence has been recorded. When a link to
previous data is identiﬁed, STRSeq provides nomenclature in-
formation and leads the analyst to published allele frequency data
(see Fig. 4).
5. Future directions for STRSeq
As previously described, sample sets and STRs will be added itera-
tively, allowing the BioProject to be built further and records to be
released in phases. Once created, the GenBank records are expected to
be stable but STRSeq should be viewed as a dynamic resource.
Some users will be familiar with NCBI interfaces and will quickly
adapt their workﬂows to access, search, and download records con-
tained in the STRSeq BioProject. While many tutorials exist to facilitate
access to NCBI resources (see https://www.ncbi.nlm.nih.gov/guide/
all/#howtos), it is likely that most users will prefer customized inter-
face tools speciﬁc to this BioProject. Future plans include the devel-
opment of such tools at strseq.nist.gov, in order to streamline BLAST
searches and batch record downloads from the BioProject.
Additionally, we aim to provide a pathway for submission of new
sequence records from laboratories performing population sample se-
quencing. We anticipate an integrated, seamless process whereby users
upload population sample sequencing data to the STRidER web portal
(http://strider.online) [10] for quality control, and STRidER queries
STRSeq for a matching sequence accession number. In cases where the
STRidER query ﬁnds no match in STRSeq, a process could be initiated
to evaluate the sequence and then aim to create a new GenBank record.
Such a process would strengthen the STRidER quality control function
and expand STRSeq, while harmonizing nomenclature between both
resources. This is particularly important for novel sequence variants
likely to be encountered as population studies extend their geographic
scope or sample numbers.
Table 1
STRSeq BioProject hierarchy, accession numbers, and direct links to all levels. The
highest-level of organization is the STRSeq umbrella project (PRJNA380127, ncbi.nlm.-
nih.gov/bioproject/380127), containing four sub-umbrella projects: (a) Commonly Used
Autosomal STR Loci, (b) Alternate Autosomal STR Loci, (c), Y-Chromosomal STR Loci and
(d) X-Chromosomal STR Loci. Each of these contains locus-speciﬁc sub-projects, which
are the data-level projects containing GenBank sequence records.
a
Commonly Used Autosomal STR Loci − PRJNA380345
ncbi.nlm.nih.gov/bioproject/380345
D1S1656 PRJNA380553 ncbi.nlm.nih.gov/bioproject/380553
TPOX PRJNA380554 ncbi.nlm.nih.gov/bioproject/380554
D2S441 PRJNA380555 ncbi.nlm.nih.gov/bioproject/380555
D2S1338 PRJNA380556 ncbi.nlm.nih.gov/bioproject/380556
D3S1358 PRJNA380558 ncbi.nlm.nih.gov/bioproject/380558
FGA PRJNA380559 ncbi.nlm.nih.gov/bioproject/380559
D5S818 PRJNA380560 ncbi.nlm.nih.gov/bioproject/380560
CSF1PO PRJNA380561 ncbi.nlm.nih.gov/bioproject/380561
SE33 PRJNA380562 ncbi.nlm.nih.gov/bioproject/380562
D6S1043 PRJNA380563 ncbi.nlm.nih.gov/bioproject/380563
D7S820 PRJNA380564 ncbi.nlm.nih.gov/bioproject/380564
D8S1179 PRJNA380565 ncbi.nlm.nih.gov/bioproject/380565
D10S1248 PRJNA380566 ncbi.nlm.nih.gov/bioproject/380566
TH01 PRJNA380567 ncbi.nlm.nih.gov/bioproject/380567
vWA PRJNA380568 ncbi.nlm.nih.gov/bioproject/380568
D12S391 PRJNA380569 ncbi.nlm.nih.gov/bioproject/380569
D13S317 PRJNA380570 ncbi.nlm.nih.gov/bioproject/380570
Penta E PRJNA380571 ncbi.nlm.nih.gov/bioproject/380571
D16S539 PRJNA380572 ncbi.nlm.nih.gov/bioproject/380572
D18S51 PRJNA380573 ncbi.nlm.nih.gov/bioproject/380573
D19S433 PRJNA380574 ncbi.nlm.nih.gov/bioproject/380574
D21S11 PRJNA380575 ncbi.nlm.nih.gov/bioproject/380575
Penta D PRJNA380576 ncbi.nlm.nih.gov/bioproject/380576
D22S1045 PRJNA380577 ncbi.nlm.nih.gov/bioproject/380577
b
Alternate Autosomal STR Loci − PRJNA380346
ncbi.nlm.nih.gov/bioproject/380346
D1S1677 PRJNA396107 ncbi.nlm.nih.gov/bioproject/396107
D2S1776 PRJNA396108 ncbi.nlm.nih.gov/bioproject/396108
D3S4529 PRJNA396109 ncbi.nlm.nih.gov/bioproject/396109
D4S2408 PRJNA396110 ncbi.nlm.nih.gov/bioproject/396110
D5S2800 PRJNA396111 ncbi.nlm.nih.gov/bioproject/396111
D6S474 PRJNA396112 ncbi.nlm.nih.gov/bioproject/396112
D9S1122 PRJNA396113 ncbi.nlm.nih.gov/bioproject/396113
D12ATA63 PRJNA396114 ncbi.nlm.nih.gov/bioproject/396114
D14S1434 PRJNA396115 ncbi.nlm.nih.gov/bioproject/396115
D17S1301 PRJNA396116 ncbi.nlm.nih.gov/bioproject/396116
D20S482 PRJNA396117 ncbi.nlm.nih.gov/bioproject/396117
c
Y-Chromosomal STR Loci − PRJNA380347
ncbi.nlm.nih.gov/bioproject/380347
DYF387S1 PRJNA396118 ncbi.nlm.nih.gov/bioproject/396118
DYS19 PRJNA396119 ncbi.nlm.nih.gov/bioproject/396119
DYS385 a/b PRJNA396120 ncbi.nlm.nih.gov/bioproject/396120
DYS389 I/II PRJNA396122 ncbi.nlm.nih.gov/bioproject/396122
DYS390 PRJNA396123 ncbi.nlm.nih.gov/bioproject/396123
DYS391 PRJNA396124 ncbi.nlm.nih.gov/bioproject/396124
DYS392 PRJNA396125 ncbi.nlm.nih.gov/bioproject/396125
DYS393 PRJNA396126 ncbi.nlm.nih.gov/bioproject/396126
DYS437 PRJNA396127 ncbi.nlm.nih.gov/bioproject/396127
DYS438 PRJNA396128 ncbi.nlm.nih.gov/bioproject/396128
DYS439 PRJNA396129 ncbi.nlm.nih.gov/bioproject/396129
DYS448 PRJNA396130 ncbi.nlm.nih.gov/bioproject/396130
DYS456 PRJNA396131 ncbi.nlm.nih.gov/bioproject/396131
DYS458 PRJNA396132 ncbi.nlm.nih.gov/bioproject/396132
DYS460 PRJNA396134 ncbi.nlm.nih.gov/bioproject/396134
Table 1 (continued)
c
Y-Chromosomal STR Loci − PRJNA380347
ncbi.nlm.nih.gov/bioproject/380347
DYS481 PRJNA396135 ncbi.nlm.nih.gov/bioproject/396135
DYS505 PRJNA396136 ncbi.nlm.nih.gov/bioproject/396136
DYS522 PRJNA396137 ncbi.nlm.nih.gov/bioproject/396137
DYS533 PRJNA396138 ncbi.nlm.nih.gov/bioproject/396138
DYS549 PRJNA396139 ncbi.nlm.nih.gov/bioproject/396139
DYS570 PRJNA396140 ncbi.nlm.nih.gov/bioproject/396140
DYS576 PRJNA396141 ncbi.nlm.nih.gov/bioproject/396141
DYS612 PRJNA396142 ncbi.nlm.nih.gov/bioproject/396142
DYS635 PRJNA396143 ncbi.nlm.nih.gov/bioproject/396143
DYS643 PRJNA396144 ncbi.nlm.nih.gov/bioproject/396144
Y-GATA-H4 PRJNA396145 ncbi.nlm.nih.gov/bioproject/396145
d
X-Chromosomal STR Loci − PRJNA380348
ncbi.nlm.nih.gov/bioproject/380348
DXS7132 PRJNA396146 ncbi.nlm.nih.gov/bioproject/396146
DXS7423 PRJNA396147 ncbi.nlm.nih.gov/bioproject/396147
DXS8378 PRJNA396148 ncbi.nlm.nih.gov/bioproject/396148
DXS10074 PRJNA396149 ncbi.nlm.nih.gov/bioproject/396149
DXS10103 PRJNA396150 ncbi.nlm.nih.gov/bioproject/396150
DXS10135 PRJNA396151 ncbi.nlm.nih.gov/bioproject/396151
HPRTB PRJNA396152 ncbi.nlm.nih.gov/bioproject/396152
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